Jane Street’s Cidara Therapeutics CDTX Stock Holding History

Jane Street’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-154,200	Closed	-$34.1M	–	11693
2025 Q4	$34.1M	Buy	154,200 +3,300	+2%	+$533K	0.01%	1166
2025 Q3	$14.5M	Buy	150,900 +146,700	+3,493%	+$9.36M	﹤0.01%	1979
2025 Q2	$205K	Buy	+4,200	New	+$101K	﹤0.01%	8505

Jane Street's CDTX Position: Q4 2025 in Review

Jane Street sold out of Cidara Therapeutics (CDTX) in Q4 2025, closing a stake of 14,604 shares — an estimated $2.36M sold.

Jane Street first reported a position in CDTX in Q1 2020 and held it in 11 quarters. The position peaked at $1.4M in Q3 2025. 255 funds tracked by Wall St. Rank hold CDTX as of Q4 2025.

Jane Street reported no remaining Cidara Therapeutics position as of Q4 2025 after selling out during the quarter.
Jane Street sold 14,604 Cidara Therapeutics shares in Q4 2025, an estimated $2.36M.
Jane Street first reported a position in Cidara Therapeutics in Q1 2020 and held it in 11 quarters.
Jane Street's Cidara Therapeutics position peaked at $1.4M in Q3 2025.
255 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.